Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-05

FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

The FDA approved Jubilant Cadista's supplemental application for the generic drug valsartan. Valsartan is used to treat hypertension, heart failure, and to redu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan (generic) (valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)